| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.4 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |